BCK Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-46,317
Closed -$1.38M 47
2025
Q3
$1.38M Buy
46,317
+29,317
+172% +$979K 1.47% 21
2025
Q2
$505K Hold
17,000
0.44% 62
2025
Q1
$519K Hold
17,000
0.4% 50
2024
Q4
$673K Hold
17,000
0.49% 41
2024
Q3
$659K Hold
17,000
0.39% 47
2024
Q2
$715K Buy
+17,000
New +$580K 0.46% 51

Other funds holding SRDX

BCK Capital Management's SRDX Position: Q4 2025 in Review

BCK Capital Management sold out of Surmodics (SRDX) in Q4 2025, closing a stake of 46,317 shares — an estimated $1.38M sold.

BCK Capital Management first reported a position in SRDX in Q2 2024 and held it in 6 quarters. The position peaked at $1.38M in Q3 2025. 1 fund tracked by Wall St. Rank holds SRDX as of Q4 2025.

  • BCK Capital Management reported no remaining Surmodics position as of Q4 2025 after selling out during the quarter.
  • BCK Capital Management sold 46,317 Surmodics shares in Q4 2025, an estimated $1.38M.
  • BCK Capital Management first reported a position in Surmodics in Q2 2024 and held it in 6 quarters.
  • BCK Capital Management's Surmodics position peaked at $1.38M in Q3 2025.
  • 1 fund tracked by Wall St. Rank held Surmodics as of Q4 2025.

Based on BCK Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.